Editorial comment: "Diffuse glioma, not otherwise specified: imaging-based risk stratification achieves histomolecular-level prognostication"
- PMID: 36100776
- DOI: 10.1007/s00330-022-09098-3
Editorial comment: "Diffuse glioma, not otherwise specified: imaging-based risk stratification achieves histomolecular-level prognostication"
Comment on
-
Diffuse glioma, not otherwise specified: imaging-based risk stratification achieves histomolecular-level prognostication.Eur Radiol. 2022 Nov;32(11):7780-7788. doi: 10.1007/s00330-022-08850-z. Epub 2022 May 19. Eur Radiol. 2022. PMID: 35587830
References
-
- Ostrom QT, Cioffi G, Waite K et al (2021) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018. Neuro Oncol 23:iii1–iii105 - DOI
-
- Louis DN, Wesseling P, Paulus W et al (2018) cIMPACT-NOW update 1: not otherwise specified (NOS) and not elsewhere classified (NEC). Acta Neuropathol 135:481–484 - DOI
-
- Do YA, Cho SJ, Choi BS et al (2022) Predictive accuracy of T2-FLAIR mismatch sign for the IDH-mutant, 1p/19q noncodeleted low-grade glioma: an updated systematic review and meta-analysis. Neurooncol Adv 4:vdac010
-
- Lasocki A, Buckland ME, Drummond KJ et al (2022) Conventional MRI features can predict the molecular subtype of adult grade 2-3 intracranial diffuse gliomas. Neuroradiology. https://doi.org/10.1007/s00234-022-02975-0
-
- Wu W, Wang Y, Xiang J et al (2022) A novel multi-omics analysis model for diagnosis and survival prediction of lower-grade glioma patients. Front Oncol 12:729002 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
